Many years of engagement with the many stakeholders in medical device development has taught Lucid to take a holistic approach. Regulatory compliance, clinical efficacy and health economic impact are all imperative to success. Understanding the potential impact of innovation on clinical protocol is equally vital.
Infection Prevention Specialists are critical to facilitating clinical investigation and in enabling adoption. With their unique insight into infection risks, current and future concerns to all healthcare organisations, infection control input is a vital piece of the route to market for most medical devices.
Lucid uses storyboards, basic and working prototypes to explain and develop proposals for new clinical protocols and device use as early in the design process as possible. Making the right, informed decisions can significantly accelerate development and our proximity to major teaching hospitals and contacts in community services means critical access to experts who can help.
As Lucid’s MD Alistair Williamson said, “Lucid continually interacts with specialists keen to help with infection prevention issues. The NHS is full of people who want to improve their patient’s quality of life and they play a major part in our work.”